+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years +
All Genders
ID06937957

Phase I Trial of BR111 Injection to Assess Safety and Effectiveness in Adults with Advanced Cancers

Led by BioRay Pharmaceutical Co., Ltd. · Updated on 2025-11-21

166

Participants Needed

1

Research Sites

11 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting a Phase I, multicenter, open-label clinical trial to study BR111-101 for injection in patients with advanced cancers. This first-in-human study aims to assess the safety, tolerability, how the drug moves through the body, its anti-tumor effects, and immune response in patients whose cancers are advanced and have limited treatment options. The trial is sponsored by BioRay Pharmaceutical Co., Ltd. and focuses on patients with advanced solid tumors or relapsedrefractory B-cell lymphoma. BR111-101 will be given as an intravenous drip, with the first dose lasting at least 90 minutes and later doses possibly reduced to 30 minutes if well tolerated. The dose is based on body weight and may be adjusted depending on prior results. Treatment will continue until intolerable side effects, disease progression, pregnancy, withdrawal, death, or study discontinuation. The study includes a dose escalation phase to find the maximum tolerated dose and recommended dose for future studies. Participants will provide tumor samples for biomarker analysis and undergo regular assessments including safety monitoring, immune response tests, and tumor evaluations. Researchers will measure the maximum tolerated dose, recommended phase 2 dose, anti-drug antibodies, drug concentration, and objective response rates. The study duration for dose escalation is about 9 months, with follow-up for immune response continuing until 30 days after the last dose or if new cancer treatment starts. Participants will be closely monitored throughout the trial for safety and treatment effects.

CONDITIONS

Brief Title

A Study of BR111 in Patients With Advanced Malignancies

Research Team

Z

Zhimin Shao, Doctoral Degree

J

Jian Zhang, Doctoral Degree

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here